A yeast that could be used to prevent invasive candidiasis – a major cause of death in hospitalized and immunocompromised ...

Of those patients, 221 patients who completed 12 weeks of follow-up with invasive candidiasis were analyzed, including 196 (89%) pediatric patients (Table, Supplemental Digital Content 1 ...

Background: Invasive candidiasis is an increasing problem in neonatal intensive care units worldwide and is an important cause of morbidity, mortality and prolongation of hospital stay.

Invasive candidiasis is the term for when a yeast infection has spread to other organs of the body. "This induces an inflammatory response and activates your body's immune system to try to clear ...

In severe cases, untreated yeast infections may enter the bloodstream and lead to a severe infection (invasive candidiasis) that can affect your heart, brain, blood, and eyes. How do you know if a ...

The following is a summary of “Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the ...

An estimated 1.5 million deaths worldwide are attributed to invasive fungal diseases annually. 5 Of these, hospital-acquired infections—most frequently caused by species of Candida—account for ...

At IDWeek 2024 [the annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on SCYNEXIS (SCYX – Research Report) yesterday and set a price target of ...

which would enable the re-start of the Phase 3 MARIO trial in invasive candidiasis, anticipated in early 2025.” said David Angulo, M.D., President and Chief Executive Officer. “Additionally ...

Reason for decision Not eligible for Health Technology Evaluation guidance Further information Decision makers have concluded that this technology will not progress as a potential technology appraisal ...

Clinical study reports for the FURI, CARES and NATURE trials in refractory or resistant invasive fungal infections were delivered to GSK, ...